NASDAQ: ADGM
Adagio Medical Holdings Inc Stock Forecast, Predictions & Price Target

Analyst price target for ADGM

Based on 1 analyst offering 12 month price targets for Adagio Medical Holdings Inc

Min Forecast
$4.00+300%
Avg Forecast
$4.00+300%
Max Forecast
$4.00+300%

Should I buy or sell ADGM stock?

Based on 1 analyst offering ratings for Adagio Medical Holdings Inc.

Strong Buy
Strong Buy
1 analysts 100%
Buy
0 analysts 0%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their ADGM stock forecasts and price targets.

ADGM stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2025-12-02

1 of 1

Forecast return on equity

Is ADGM forecast to generate an efficient return?

Forecast return on assets

Is ADGM forecast to generate an efficient return on assets?

Company
-80.12%
Industry
13.28%
ADGM is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

ADGM earnings per share forecast

What is ADGM's earnings per share in the next 3 years based on estimates from 3 analysts?

Avg 1 year Forecast
-$1.01
Avg 2 year Forecast
-$1.09
Avg 3 year Forecast
-$1.19

ADGM revenue forecast

What is ADGM's revenue in the next 3 years based on estimates from 3 analysts?

Avg 1 year Forecast
$0.0-100%
Avg 2 year Forecast
$1.8M+1,240.15%
Avg 3 year Forecast
$6.3M+4,516.06%
ADGM's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

ADGM revenue growth forecast

How is ADGM forecast to perform vs Medical Devices companies and vs the US market?

Company
345.58%
Industry
12.34%
Market
56.5%
ADGM's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
ADGM's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

ADGM vs Medical Device Stocks

TickerPricePrice TargetUp/downsideConsensus
ADGM$1.00$4.00+300.00%Strong Buy
IINN$0.75N/AN/A
COCH$0.65N/AN/A
NSYS$8.87N/AN/A
IRIX$1.49N/AN/A

Adagio Medical Holdings Stock Forecast FAQ

Is Adagio Medical Holdings Stock a good buy in 2026, according to Wall Street analysts?

The consensus among 1 Wall Street analyst covering (NASDAQ: ADGM) stock is to Strong Buy ADGM stock.

Out of 1 analyst, 1 (100%) are recommending ADGM as a Strong Buy, 0 (0%) are recommending ADGM as a Buy, 0 (0%) are recommending ADGM as a Hold, 0 (0%) are recommending ADGM as a Sell, and 0 (0%) are recommending ADGM as a Strong Sell.

If you're new to stock investing, here's how to buy Adagio Medical Holdings stock.

What is ADGM's earnings growth forecast for 2026-2028?

(NASDAQ: ADGM) Adagio Medical Holdings's forecast annual earnings growth rate of N/A is not forecast to beat the US Medical Devices industry's average forecast earnings growth rate of 23.35%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 102.53%.

Adagio Medical Holdings's earnings in 2026 is -$79,147,000.On average, 3 Wall Street analysts forecast ADGM's earnings for 2026 to be -$21,387,197, with the lowest ADGM earnings forecast at -$20,548,484, and the highest ADGM earnings forecast at -$22,016,233. On average, 3 Wall Street analysts forecast ADGM's earnings for 2027 to be -$23,115,456, with the lowest ADGM earnings forecast at -$22,208,967, and the highest ADGM earnings forecast at -$23,795,322.

In 2028, ADGM is forecast to generate -$25,275,779 in earnings, with the lowest earnings forecast at -$24,284,572 and the highest earnings forecast at -$26,019,184.

What is ADGM's revenue growth forecast for 2026-2028?

(NASDAQ: ADGM) Adagio Medical Holdings's forecast annual revenue growth rate of 345.58% is forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 12.34%, and it is also forecast to beat the US market's average forecast revenue growth rate of 56.5%.

Adagio Medical Holdings's revenue in 2026 is $137,000.On average, 3 Wall Street analysts forecast ADGM's revenue for 2026 to be $0, with the lowest ADGM revenue forecast at $0, and the highest ADGM revenue forecast at $0. On average, 3 Wall Street analysts forecast ADGM's revenue for 2027 to be $38,885,814, with the lowest ADGM revenue forecast at $37,360,880, and the highest ADGM revenue forecast at $40,029,514.

In 2028, ADGM is forecast to generate $133,940,024 in revenue, with the lowest revenue forecast at $128,687,474 and the highest revenue forecast at $137,879,437.

What is ADGM's forecast return on assets (ROA) for 2026-2028?

(NASDAQ: ADGM) forecast ROA is -80.12%, which is lower than the forecast US Medical Devices industry average of 13.28%.

What is ADGM's Price Target?

According to 1 Wall Street analyst that have issued a 1 year ADGM price target, the average ADGM price target is $4.00, with the highest ADGM stock price forecast at $4.00 and the lowest ADGM stock price forecast at $4.00.

The Wall Street analyst predicted that Adagio Medical Holdings's share price could reach $4.00 by Dec 2, 2026. The average Adagio Medical Holdings stock price prediction forecasts a potential upside of 300% from the current ADGM share price of $1.00.

What is ADGM's Earnings Per Share (EPS) forecast for 2026-2028?

(NASDAQ: ADGM) Adagio Medical Holdings's current Earnings Per Share (EPS) is -$4.98. On average, analysts forecast that ADGM's EPS will be -$1.01 for 2026, with the lowest EPS forecast at -$0.97, and the highest EPS forecast at -$1.04. On average, analysts forecast that ADGM's EPS will be -$1.09 for 2027, with the lowest EPS forecast at -$1.05, and the highest EPS forecast at -$1.12. In 2028, ADGM's EPS is forecast to hit -$1.19 (min: -$1.15, max: -$1.23).

What is ADGM's forecast return on equity (ROE) for 2026-2028?

(NASDAQ: ADGM) forecast ROE is N/A, which is considered weak.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.